HEPATOPROTECTIVE, ANTIDIABETIC, AND ANTIPYRETIC ACTIVITY STUDIES OF SIDDHA FORMULATION – NILAVEMBU KUDINEER

  • KASIRAJAN N Department of Maruthuvam, Tirunelveli, Tamil Nadu, India.
  • MAHESHWARI B Department of Maruthuvam, Government Siddha Medical College, Palayamkottai, Tirunelveli, Tamil Nadu, India.
  • SUBASHCHANDRAN G Department of Maruthuvam, Government Siddha Medical College, Palayamkottai, Tirunelveli, Tamil Nadu, India.
  • MAANICKHA CHELVI KS Department of Clinical Research, Siddha Regional Research Institute, Thiruvananthapuram, Kerala, India.

Abstract

Objective: Traditional medicines like Siddha System of Medicine are one of the most primitive medical system. It plays a major role in treating ailments of humankind. Nowadays, this system flourished throughout India using Nilavembu kudineer (NVK) as a drug to treat in various outbreaks such as dengue, Chikungunya, and other related virus infections. As per literature, NVK indicated many types of fever and various diseases. This study emphasizes on antipyretic, antidiabetic, and hepato protective activities of NVK by In vitro study methods.


Methods: Hepatoprotective effect of NVK on Carbon tetrachloride-induced hepatotoxicity in the rat in five groups, antipyretic activity tested by subcutaneous injection of 10 ml/kg of 15% w/v yeast suspended in 0.5% w/v carboxymethyl cellulose solution for elevation of body temperature of rats in 6 groups. Antidiabetic activity done by administration of streptozotocin dissolved in citrate buffer (pH 4.5) and nicotinamide, intraperitoneal injection of 60 mg/kg streptozotocin, 15 min after the i.p administration of 120 mg/kg of nicotinamide in non-insulin-dependent diabetes, in six groups.


Results: The hepatoprotective effect having the significance of one way ANOVA followed by Dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, and ***p<0.001, calculated by comparing treated groups tumor with the control group. Antidiabetic activity having the significance of Dunnett’s ***p<0.001, **p<0.01, and *p<0.05 calculated by comparing the treated group with the control group and antipyretic activity results in Dunnett’s *p<0.05 calculated by comparing the treated group with the control group were considered to be significant.


Conclusion: The study shows that NVK having the potency of hepatoprotective and capability of diabetes in vitro studies. This study also revealed the potency of antipyretic activity against yeast.

Keywords: Nilavembu kudineer, Hepatoprotective effect, Antidiabetic activity, Antipyretic activity, Statistically significant

Author Biography

KASIRAJAN N, Department of Maruthuvam, Tirunelveli, Tamil Nadu, India.

siddha department

References

1. Jain J, Kumar A, Narayanan V, Ramaswamy RS, Sathiyarajeswaran P, Devi MS, et al. Antiviral activity of ethanolic extract of nilavembu kudineer against dengue and chikungunya virus through in vitro evaluation. J Ayurveda Integr Med 2018;1:76-80.
2. Sathya B, Velpandian V, Ramani M, Kumar A. Primitive approach on review of siddha herbs, herbo-mineral formulation exhibiting antiviral activity. Int J Pharma Bio Sci 2014;5:138-47.
3. Christian GJ, Subramanian M, Periyasami D, Manickavasakam K, Gunasekaran P, Sivasubramanian S, et al. Protective effect of polyherbal siddha formulation-nilavembu kudineer against common viral fevers including dengue-a case control approach. IJPSR 2015;6:1656-60.
4. Uma KS, Jacob M, Arumugam G, Kalpana S, Natarajan M. In vitro Antimicrobial activity of the siddha drugs seenthil Sarkarai and nilavembu kudineer against Leptospira. Int J Pharm Pharm Sci 2012;4:75-8.
5. Sahabudeen S, Nag H, Madhavan S, Chatterjee A, Dan P, Bhattacharya M, et al. Fecundity studies of Andrographis paniculata on Drosophila melanogaster. Int J Pharm Pharm Sci 2019;11:23-7.
6. Maiti K, Mukherjee K, Murugan V, Saha BP, Mukherjee PK. Enhancing bioavailability and hepato protective activity of andrographolide from Andrographis paniculata, a well-known medicinal food, through its herbo some. J Sci Food Agric 2010;90:43-51.
7. Castro JA, De Ferreyra EC, De Castro CR, De Fenos OM, Sasame H, Gillette JR. Prevention of carbon tetrachloride-induced necrosis by inhibitors of drug metabolism-further studies on their mechanism of action. Biochem Pharmacol 1974;23:295-2.
8. Parola M, Leonarduzz G, Biasi F, Albono M, Biocca G, Dianzani MU. Vitamin E dietary supplementation. Protects against CCl4 induced chronic liver damage and cirrhosis. Hepatology 1992;16:1014-21.
9. Poli G. Liver damage due to free radicals. Br Med Bull 1993;49:604-20.
10. Marudamuthu AS, Leelavinothan P. Effect of pterostilbene on lipids and lipid profiles for diabetes, in streptozotocin-nicotinamide induced Type 2 diabetes mellitus. J Appl Biomed 2008;6:31-7.
11. Singh A, Bhat TK, Sharma OP. Clinical biochemistry of hepatotoxicity. J Clin Toxicol 2011;4:210-7.
12. Pandit A, Sachdeva T, Bafna P. Drug-induced hepatotoxicity: A review.J Appl Pharm Sci 2012;2:233-43.
13. Kumar A. A review on hepatoprotective herbal drugs. IJRPC 2012;2:92-2.
14. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology 2001;34:595-3.
15. Dhingra M, Nain P, Nain J, Malik M. Hepatotoxicity v/s hepato protective agents-a pharmacological review. IRJP 2011;2:31-7.
16. Johnston DE, Kroening C. Mechanism of early carbon tetrachloride toxicity in cultured rat hepatocytes. Pharmacol Toxicol 1998;83:231-9.
17. Srivastava SP, Chen NO, Holtzman JL. The in vitro NADPH dependent inhibition by CCl4 of the ATP-dependent calcium uptake of hepatic microsomes from male rats. Studies on the mechanism of inactivation of the hepatic microsomal calcium pump by the CCl3 radical. J Biol Chem 1990;265:8392-9.
18. Recknagel RO, Glende EA, Hruszkewycz AM. Free Radicals in Biology. Vol. 3. New York: Academic Press; 1977. p. 97-32.
19. De Groot H, Noll T. The crucial role of low steady state oxygen partial pressures in haloalkane free-radical mediated lipid peroxidation. Biochem Pharmacol 1986;35:15.
20. Al-Harbi MS. Hepatoprotective effect and antioxidant capacity of naringenin on arsenic-induced liver injury in rats. Int J Pharm Pharm Sci 2016;8:103-8.
21. Saxena S, Jain DC, Gupta MM, Bhakuni RS, Mishra HO, Sharma RP. High-performance thin-layer chromatographic analysis of hepatoprotective diterpenoids from Andrographis paniculata. Phytochem Anal 2000;11:34-6.
22. Putta W, Chedalawada V. Dose dependent effect on hypoglycemic and antihyperglycemic activities of chloroform extract of physalis minima in streptozotocin induced diabetic rats. Int J Curr Pharm Res 2014;6:61-5.
23. Raut NA, Gaikwad NJ. Antidiabetic activity of hydro-ethanolic extract of Cyperus rotundus in alloxan induced diabetes in rats. Fitoterapia 2006;77:585-8.
24. Al-Amin ZM, Thomson M. Anti-diabetic and hypo lipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006;96:660-6.
25. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, et al. A Phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 2000;14:333-8.
26. Suebsasana S, Pongnaratorn P, Sattayasai J, Arkaravichien T, Tiamkao S, Aromdee C. Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch Pharm Res 2009;32:1191-200.
27. Vedavathy S, Rao KN. Antipyretic activity of six indigenous medicinal plants of Tirumala Hills, Andhra Pradesh, India. J Ethnopharmacol 1991;33:193-6.
Statistics
20 Views | 30 Downloads
Citatons
How to Cite
N, K., M. B, S. G, and M. C. KS. “HEPATOPROTECTIVE, ANTIDIABETIC, AND ANTIPYRETIC ACTIVITY STUDIES OF SIDDHA FORMULATION – NILAVEMBU KUDINEER”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 9, June 2020, pp. 115-9, doi:10.22159/ajpcr.2020.v13i9.38041.
Section
Original Article(s)